Filter by: patients
Home > Evaluations from Patients who take Parkinson's Phase 3 Study Safinimide

Parkinson's Phase 3 Study Safinimide Treatment Report

Category: Others

false

See also: Clinical Trial

Sort by: Helpfulness | Most Recent

1 patient evaluation for Parkinson's Phase 3 Study Safinimide

Purpose: Parkinson's Disease (Started Feb 25, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jan 01, 2012   Led_efficacy_1Led_defaultLed_defaultLed_defaultNone ModerateModerateModerateModerateModerate AlwaysAlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhatSomewhat
Aug 01, 2011 1 other Daily Led_efficacy_1Led_defaultLed_defaultLed_defaultNone NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Mar 28, 2011 1 other Daily Led_efficacy_2Led_efficacy_2Led_defaultLed_defaultSlight MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Side effects:
Moodiness
Date
Jan 01, 2012
Advice & Tips
I would not recommend that you participate in the drug study. The photogrphs of the eye were awful.
Cost
< $25 monthly
Date
Aug 01, 2011
Advice & Tips
I was on a double blind study so I never knew if I was taking Safinimide. The eye photos were grurling.
Cost
< $25 monthly
Date
Mar 28, 2011
Advice & Tips
I am enrolled in a double blind drug study and do not know if I am on safinimide 100 mg day or placebo.
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks